The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited
Open Access
- 19 December 2007
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 19 (4) , 655-659
- https://doi.org/10.1093/annonc/mdm537
Abstract
Purpose: To assess the false-positive rate of breast cancer surveillance by magnetic resonance imaging (MRI) in BRCA mutation carriers and the impact of an abnormal mammography or breast MRI on the patients’ decision for prophylactic mastectomy. Patients and methods: A total of 196 BRCA mutation carriers were included with a median follow-up of 2 years (range 1–9) with annual mammography and MRI. Preference for prophylactic mastectomy was registered at first surveillance after the mutation carriership was revealed. Results: In all, 41% (81 of 196) of the women had at least one positive MRI or mammography. Malignancy was detected in 17 women: 11 at surveillance, 4 at an intended prophylactic mastectomy and 2 had an interval cancer. Imaging by mammography and MRI had a sensitivity of 71% and a specificity of 90%. The probability that a positive MRI result is false positive was 83%. In the group with a prior preference for mastectomy with and without a false–positive imaging, prophylactic mastectomy was carried out in 89% and 66%, respectively (P = 0.06), in the group with prior preference for surveillance these percentages were 15% and 11%, respectively (P = 0.47). Conclusion: Although the rate of false-positive MRI results is high, the impact on the choice for prophylactic mastectomy is limited and is determined by the woman’s preference before the establishment of a BRCA mutation.Keywords
This publication has 24 references indexed in Scilit:
- Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective seriesThe Breast, 2007
- Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic reviewInternational Journal of Cancer, 2007
- Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusInternational Journal of Cancer, 2007
- Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 MutationAnnals of Internal Medicine, 2006
- Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic PredispositionNew England Journal of Medicine, 2004
- High-Risk Lesions in High-Risk WomenJournal of Clinical Oncology, 2004
- Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up StudyJournal of Clinical Oncology, 2003
- Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessmentBritish Journal of Cancer, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Acceptability of Prophylactic Mastectomy in Cancer-Prone WomenJAMA, 2000